Literature DB >> 15464747

Regional brain cholecystokinin changes as a function of friendly and aggressive social interactions in rats.

Jaak Panksepp1, Jeff Burgdorf, Margery C Beinfeld, Roger A Kroes, Joseph R Moskal.   

Abstract

Cholecystokinin (CCK) is the most abundant neuropeptide in the mammalian brain, and has been implicated in the regulation of a diversity of emotions and motivations including negative affect and stress responses. In this experiment, we assayed levels of CCK (CCK4/5 and CCK8) from tissue homogenates in intruder animals 6 h after resident-intruder inter-male aggression. Intruder animals that demonstrated submissive behavior (freezing and 22-kHz ultrasonic vocalizations) had higher levels of CCK in the tegmentum and posterior cortex as compared to non-submissive (i.e., "Friendly") intruder animals. Ultrasonic vocalizations (22-kHz) were positively correlated with CCK levels in the tegmentum, posterior cortex and pituitary. These data suggest that CCK may play a role in the generation of negative affective states indexed by 22-kHz ultrasonic calls in certain regions of the brain.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15464747     DOI: 10.1016/j.brainres.2004.07.076

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  17 in total

1.  Sulfation, the up-and-coming post-translational modification: its role and mechanism in protein-protein interaction.

Authors:  Amina S Woods; Hay-Yan J Wang; Shelley N Jackson
Journal:  J Proteome Res       Date:  2007-01-26       Impact factor: 4.466

2.  Social defeat, a paradigm of depression in rats that elicits 22-kHz vocalizations, preferentially activates the cholinergic signaling pathway in the periaqueductal gray.

Authors:  Roger A Kroes; Jeffrey Burgdorf; Nigel J Otto; Jaak Panksepp; Joseph R Moskal
Journal:  Behav Brain Res       Date:  2007-03-25       Impact factor: 3.332

3.  Interaction between cholecystokinin and the fibroblast growth factor system in the ventral tegmental area of selectively bred high- and low-responder rats.

Authors:  S J Ballaz; J Perez; M Waselus; H Akil; S J Watson
Journal:  Neuroscience       Date:  2013-10-09       Impact factor: 3.590

Review 4.  Modulation of nociception by social factors in rodents: contribution of the opioid system.

Authors:  Francesca R D'Amato; Flaminia Pavone
Journal:  Psychopharmacology (Berl)       Date:  2012-09-20       Impact factor: 4.530

5.  κ-opioid receptor as a key mediator in the regulation of appetitive 50-kHz ultrasonic vocalizations.

Authors:  Adam Hamed; Janusz Szyndler; Ewa Taracha; Danuta Turzyńska; Alicja Sobolewska; Małgorzata Lehner; Paweł Krząścik; Patrycja Daszczuk
Journal:  Psychopharmacology (Berl)       Date:  2014-12-04       Impact factor: 4.530

Review 6.  Is the use of sentient animals in basic research justifiable?

Authors:  Ray Greek; Jean Greek
Journal:  Philos Ethics Humanit Med       Date:  2010-09-08       Impact factor: 2.464

7.  Phencyclidine-induced social withdrawal results from deficient stimulation of cannabinoid CB₁ receptors: implications for schizophrenia.

Authors:  Alexandre Seillier; Alex A Martinez; Andrea Giuffrida
Journal:  Neuropsychopharmacology       Date:  2013-04-05       Impact factor: 7.853

8.  The neuropeptide Drosulfakinin regulates social isolation-induced aggression in Drosophila.

Authors:  Pavan Agrawal; Damian Kao; Phuong Chung; Loren L Looger
Journal:  J Exp Biol       Date:  2020-01-29       Impact factor: 3.312

9.  Cannabinoid Exposure via Lactation in Rats Disrupts Perinatal Programming of the Gamma-Aminobutyric Acid Trajectory and Select Early-Life Behaviors.

Authors:  Andrew F Scheyer; Milene Borsoi; Jim Wager-Miller; Anne-Laure Pelissier-Alicot; Michelle N Murphy; Ken Mackie; Olivier J J Manzoni
Journal:  Biol Psychiatry       Date:  2019-09-05       Impact factor: 13.382

10.  Blockade of the cholecystokinin CCK-2 receptor prevents the normalization of anxiety levels in the rat.

Authors:  Santiago J Ballaz; Michel Bourin; Huda Akil; Stanley J Watson
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2019-09-14       Impact factor: 5.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.